Systemic Chemotherapy as First-line Treatment for Metastatic Pancreatic Adenocarcinoma: A Bayesian Analysis-Reference-Cited by-同舟云学术

Systemic Chemotherapy as First-line Treatment for Metastatic Pancreatic Adenocarcinoma: A Bayesian Analysis

Published:2019 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Zhang Shuisheng¹²,Tian Yuan³,Xie Shuanghua⁴,Zhang Jianwei¹,Zhao Jiuda⁵,Chen Yingtai¹,Wang Chengfeng¹

Affiliation:

1. Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China

2. Department of General Surgery, Peking University Third Hospital, China

3. Department of Radiation Oncology, Shandong Provincial Qianfoshan Hospital, China

4. Department of Cancer Epidemiology and Health Statistics, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China

5. Department of Medical Oncology, Affiliated Hospital of Qinghai University, China

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1114-18/_pdf

Reference37 articles.

1. 1. Siegel RL, Miller KD, Jemal A. CA Cancer J Clin 67: 7-30, 2017.

2. 2. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364: 1817-1825, 2011.

3. 3. VonHoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369: 1691-703, 2013.

4. 4. Goldstein D, El-Maraghi RH, Hammel P, et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst 107: ★-★, 2015.

5. 5. Ades AE, Sculpher M, Sutton A, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 24: 1-19, 2006.